Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INTERFERON BETA-1A Cause Type 2 diabetes mellitus? 179 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Type 2 diabetes mellitus have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.3% of all adverse event reports for INTERFERON BETA-1A.

179
Reports of Type 2 diabetes mellitus with INTERFERON BETA-1A
0.3%
of all INTERFERON BETA-1A reports
2
Deaths
53
Hospitalizations

How Dangerous Is Type 2 diabetes mellitus From INTERFERON BETA-1A?

Of the 179 reports, 2 (1.1%) resulted in death, 53 (29.6%) required hospitalization.

Is Type 2 diabetes mellitus Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1A. However, 179 reports have been filed with the FAERS database.

What Other Side Effects Does INTERFERON BETA-1A Cause?

Multiple sclerosis relapse (5,931) Influenza like illness (4,475) Memory impairment (3,468) Multiple sclerosis (3,412) Fatigue (3,164) Fall (3,128) Gait disturbance (3,031) Death (2,766) Pain (2,692) Headache (2,533)

What Other Drugs Cause Type 2 diabetes mellitus?

ATORVASTATIN (7,556) ADALIMUMAB (3,516) PREDNISONE (3,484) METHOTREXATE (3,465) RITUXIMAB (3,318) TOCILIZUMAB (3,145) ABATACEPT (3,074) LEFLUNOMIDE (3,033) ALENDRONATE (3,002) DICLOFENAC (2,974)

Which INTERFERON BETA-1A Alternatives Have Lower Type 2 diabetes mellitus Risk?

INTERFERON BETA-1A vs INTERFERON BETA-1B INTERFERON BETA-1A vs INTERFERON GAMMA INTERFERON BETA-1A vs INTERFERON GAMMA-1B INTERFERON BETA-1A vs INVEGA INTERFERON BETA-1A vs INVEGA SUSTENNA

Related Pages

INTERFERON BETA-1A Full Profile All Type 2 diabetes mellitus Reports All Drugs Causing Type 2 diabetes mellitus INTERFERON BETA-1A Demographics